Your skin acts as a protective barrier
A 2025 review of scientific studies showed that GLP-1 medication can lead to significant reductions in weight, BMI, and waist circumference
government will be expanding coverage of a popular new drug, making it more accessible to millions of Americans
Compared to healthy controls, BD patients had higher levels of Actinobacteria and Coriobacteria , while healthy individuals had more Ruminococcaceae and Faecalibacterium , which are generally considered beneficial
Find articles by Bartlett, D
Coverage for weight loss is a different story: only 13 states cover obesity-indicated GLP-1s as of January 2026, and that number has been shrinking as states face budget pressure